Literature DB >> 19400825

Survival and late effects on development of patients with infantile brain tumor.

Yuko Nomura1, Sawa Yasumoto, Fumio Yanai, Hidetaka Akiyoshi, Takahito Inoue, Keiko Nibu, Hitoshi Tsugu, Takeo Fukushima, Shinichi Hirose.   

Abstract

BACKGROUND: Most infants with brain tumor may have a poor prognosis. The aim of the present study was to retrospectively analyze the survival and outcome with regard to mental and physical development in 11 subjects with brain tumor; these tumors were diagnosed when the patients were under 1 year of age.
METHODS: The histological diagnoses of these tumors were astrocytoma, n = 3; pineocytoma, n = 2; teratoma, n = 1; ependymoma, n = 1; atypical teratoid/rhabdoid tumor, n = 1; glioblastoma, n = 1; medulloblastoma, n = 1; and choroid plexus papilloma, n = 1. Surgical resection was performed in eight patients, and adjuvant chemotherapy was administered to all except one patient with choroid plexus papilloma. Radiotherapy was additionally performed for four of the 10 chemotherapy patients.
RESULTS: Six patients survived. Among the surviving patients, five were under no treatment for 50-167 months after the diagnosis (median duration, 89 months), while one received chemotherapy for 20 months. Five patients exhibited mental retardation, and one patient experienced normal development after surgical removal of his choroid plexus papilloma. Diencephalic syndrome developed in one patient with pilomyxoid astrocytoma that necessitated hormone replacement therapy, and bodyweight over +2 SD was observed in two patients. The remaining five patients died 11-111 months after diagnosis (median duration, 24 months).
CONCLUSION: The prognosis of infantile brain tumor with regard to mortality and developmental outcome remains poor. Furthermore, survivors require comprehensive medical and social support for an extended period.

Entities:  

Mesh:

Year:  2008        PMID: 19400825     DOI: 10.1111/j.1442-200X.2008.02760.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  6 in total

1.  Genome-wide copy number analysis in pediatric glioblastoma multiforme.

Authors:  Laura Giunti; Marilena Pantaleo; Iacopo Sardi; Aldesia Provenzano; Alberto Magi; Stefania Cardellicchio; Francesca Castiglione; Lorenzo Tattini; Francesca Novara; Anna Maria Buccoliero; Maurizio de Martino; Lorenzo Genitori; Orsetta Zuffardi; Sabrina Giglio
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

2.  Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.

Authors:  Xing Gong; Philip H Schwartz; Mark E Linskey; Daniela A Bota
Journal:  Neurology       Date:  2011-02-23       Impact factor: 9.910

3.  Distinct survival and clinical profile of infantile glioblastoma: insights from a national database.

Authors:  Victor M Lu; Daniel G Eichberg; Evan M Luther; Ashish H Shah; David J Daniels; Ossama M Maher; Toba N Niazi
Journal:  Childs Nerv Syst       Date:  2021-10-13       Impact factor: 1.475

4.  Microscopic Delineation of Medulloblastoma Margins in a Transgenic Mouse Model Using a Topically Applied VEGFR-1 Probe.

Authors:  Danni Wang; Ye Chen; Steven Y Leigh; Henry Haeberle; Christopher H Contag; Jonathan T C Liu
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

5.  Identification of cell surface targets through meta-analysis of microarray data.

Authors:  Henry Haeberle; Joel T Dudley; Jonathan T C Liu; Atul J Butte; Christopher H Contag
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

Review 6.  Late Effects in Survivors of Neonatal Cancer.

Authors:  Sanyukta K Janardan; Karen E Effinger
Journal:  Clin Perinatol       Date:  2021-01-12       Impact factor: 3.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.